Antibody tests suggest that coronavirus infections vastly exceed official counts

@article{Mallapaty2020AntibodyTS,
  title={Antibody tests suggest that coronavirus infections vastly exceed official counts},
  author={Smriti Mallapaty},
  journal={Nature},
  year={2020}
}
Study estimates a more than 50-fold increase in coronavirus infections compared to official cases, but experts have raised concerns about the reliability of antibody kits. Study estimates a more than 50-fold increase in coronavirus infections compared to official cases, but experts have raised concerns about the reliability of antibody kits. 
View on Springer
ncbi.nlm.nih.gov
34 Citations
Highly Influential Citations
1
Background Citations
11
Methods Citations
1

34 Citations

Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward
TLDR
This viewpoint discusses the pitfalls that can arise with the use of convenience samples and offers guidance for moving towards more representative and timely population estimates of COVID-19 seroprevalence.
COVID‐19: test, trace and isolate‐new epidemiological data
TLDR
In the absence of an efficient drug treatment or a vaccine, the control of the COVID‐19 pandemic relies on classic infection control measures, and better knowledge of the epidemiology of the new coronavirus epidemic is crucial to achieve control at a sustainable cost, and within tolerable restrictions of civil rights.
An investigation of testing capacity for evaluating and modeling the spread of coronavirus disease
Antibody detection assays for COVID‐19 diagnosis: an early overview
TLDR
The objective of this review is to share the diagnostic performance of various immunological assays reported so far in severe acute respiratory syndrome coronavirus 2 case detection and consolidate the studies related to serological tests in COVID‐19 diagnosis and update the current scenario.
Doing more tests: Next challenge for Covid 19 in India
  • M. Roy
  • Sociology
    VirusDisease
  • 2020
TLDR
In response to Coronavirus 19 pandemic, countries are struggling to contain its spread and save precious human lives, and doing extensive tests would emerge as a major strategy for stopping the progression of the pandemic.
Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity
SARS-CoV-2 pandemic: a review of molecular diagnostic tools including sample collection and commercial response with associated advantages and limitations
TLDR
This work puts forth key observations in the functionality of current methods for SARS-CoV-2 diagnostic testing, which include nucleic acid amplification–, CRISPR-, sequencing-, antigen-, and antibody-based detection methods.
Cross-disciplinary approaches to assist with nucleic acid testing for SARS-CoV-2
TLDR
Cross-disciplinary approaches may improve the efficiency of COVID-19 diagnosis by compensating to some extent the limitations encountered by traditional test methods during the CO VID-19 pandemic.
A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array
TLDR
A serological snapshot of Israeli patients and healthy adults in the early months of the COVID-19 pandemic confirmed a very low seroprevalence of anti-SARS-CoV-2 antibodies in the Israeli adult population, and suggested that the presence of low-level cross-reacting antibodies in naive individuals calls for a combined, multiantigen analysis for accurate discrimination between naive and exposed individuals.
Die Prävalenz von SARS-CoV-2-IgG-AK liegt bei 1,2%
TLDR
The prevalence of 1.2% of SARS-CoV-2-IgG-antibodies and consequently the rate of infection in asymptomatic outpatients in Northrhine-Westfalia (Germany) is low and the impact of virus neutralisation by antibodies and consequently immunization is the challenge of further investigations.
...
...